A/APublished research associates this genotype with typical/baseline likelihood of Response to aripiprazole in schizophrenia — no copies of the reported risk allele.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Response to aripiprazole in schizophrenia.
G/GPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Response to aripiprazole in schizophrenia compared to the general population.
rs17022006 is a single position in the genome, in or near the CNTN4 gene. Published research associates it with response to aripiprazole in schizophrenia. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs17022006 linked to?
On MyGeneLog this position is linked to Schizophrenia. The research behind each link, and its sources, are set out on that condition page.
Does having rs17022006 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs17022006 come from?
GWAS Catalog, Lancet Psychiatry 2018, PMID:29503163. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.